MedTrace Logo

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection

NCT04131569 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-10-21

No results posted yet for this study

Summary

Antimicrobial resistance is a major threat worldwide and extended-spectrum beta-lactamase producing Enterobacteriales (ESBL-E) are a leading cause because of their wide dissemination. Gut microbiota seems to be correlated with multi-drug resistant organism carriage. This study thus aims to analyse the correlation between gut microbiota, ESBL-E fecal carriage and subsequent infection.

Conditions

  • Extended Spectrum Beta-Lactamase Producing Bacteria Infection
  • Microbial Colonization
  • Critical Illness

Interventions

DIAGNOSTIC_TEST

ESBL-E fecal carriage screening according to routine care

ESBL-E fecal carriage screening according to routine care

Sponsors & Collaborators

  • University of Bordeaux

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-15
Primary Completion
2020-03-15
Completion
2020-03-15

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04131569 on ClinicalTrials.gov